Recent advancements in deep learning have significantly transformed the field of nuclear medicine, specifically in the detection and analysis of bone metastases via scintigraphy. By leveraging ...

Health-related quality of life after IMRT or IMRT+ HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial. This is an ASCO Meeting Abstract from the ...

Years to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected by metastasis and in the current study published in the journal ...

In a recent study published in Scientific Reports, a group of researchers investigated the differences in prostate magnetic resonance imaging (MRI) findings and clinical characteristics between ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. With this mda-9 mice model, Fisher and his team observed how ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases ...

Triple negative breast cancer (TNBC) is usually detected at later stages. Unfortunately, by this time the cancer has moved or metastasized to other tissues throughout the body. One of the most common ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the precision and comfort of cancer therapy. Designed by a team of researchers ...

The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation ...

Selvarangan Ponnazhagan, Ph.D., Endowed Professor in Experimental Cancer Therapeutics in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, has recently been awarded a ...